Microorganisms (Sep 2021)

COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies

  • Giuseppina Malcangi,
  • Alessio Danilo Inchingolo,
  • Angelo Michele Inchingolo,
  • Luigi Santacroce,
  • Grazia Marinelli,
  • Antonio Mancini,
  • Luigi Vimercati,
  • Maria Elena Maggiore,
  • Maria Teresa D’Oria,
  • Denisa Hazballa,
  • Ioana Roxana Bordea,
  • Edit Xhajanka,
  • Antonio Scarano,
  • Marco Farronato,
  • Gianluca Martino Tartaglia,
  • Delia Giovanniello,
  • Ludovica Nucci,
  • Rosario Serpico,
  • Gilberto Sammartino,
  • Loredana Capozzi,
  • Antonio Parisi,
  • Marina Di Domenico,
  • Felice Lorusso,
  • Maria Contaldo,
  • Francesco Inchingolo,
  • Gianna Dipalma

DOI
https://doi.org/10.3390/microorganisms9091964
Journal volume & issue
Vol. 9, no. 9
p. 1964

Abstract

Read online

Background: The SARS-CoV-2 pandemic has involved a severe increase of cases worldwide in a wide range of populations. The aim of the present investigation was to evaluate recent insights about COVID-19 infection in children, infants and pregnant subjects. Methods: a literature overview was performed including clinical trials, in vitro studies, reviews and published guidelines regarding the present paper topic. A descriptive synthesis was performed to evaluate recent insights and the effectiveness of therapies for SARS-CoV-2 infection in children, infants and pregnant subjects. Results: Insufficient data are available regarding the relationship between COVID-19 and the clinical risk of spontaneous abortion and premature foetus death. A decrease in the incidence of COVID-19 could be correlated to a minor expression of ACE2 in childrens’ lungs. At present, a modulation of the dose-effect posology for children and infants is necessary. Conclusions: Pregnant vertical transmission has been hypothesised for SARS-CoV-2 infection. Vaccines are necessary to achieve mass immunity for children and also pregnant subjects.

Keywords